What is behind Stress Resilience
The capacity to meet a challenge and return to baseline. Reactivity, not resting level, is what predicts: cortisol reactivity tracked incident hypertension, adjusted for baseline bp and resting cortisol. Only ~40% of people mount that response at all. Evidence A — Human trial evidence.
The hypothalamic–pituitary–adrenal axis and its hormone cortisol — the body's central stress-and-recovery command. Evidence A — Human trial evidence.
The transcription factor that commands the body's own antioxidant and detoxification arsenal. Evidence A — Human trial evidence.
The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.
The cell's master energy sensor — when fuel runs low it ignites fat-burning, glucose uptake and mitochondrial renewal while standing down growth. Evidence A — Human trial evidence.
A sirtuin enzyme that tunes metabolism, DNA repair and mitochondrial health toward the state linked with longer healthspan. Evidence A — Human trial evidence.
Immune surveillance — the standing patrol that detects and clears pathogens and aberrant cells. Evidence A — Human trial evidence.
Insulin-like growth factor-1 — the dermal-papilla growth factor that drives follicle proliferation and prolongs anagen (the active growth phase). Evidence A — Human trial evidence.
The sympathetic nervous system — the fight-or-flight arm that quickens the heart and mobilizes the body. Evidence B — Preclinical.
Endocannabinoid signaling — the tone-setting system that buffers stress, mood and homeostasis. Evidence B — Preclinical.
Evidence on these pathways
AMPK → Insulin Sensitivity. “In model systems, sustained decreases in AMPK activity accompany IR, whereas AMPK activation increases insulin sensitivity.” — AMPK, insulin resistance, and the metabolic syndrome. The Journal of Clinical Investigation, 2013, volume 123, issue 7, pages 2764-2772. doi:10.1172/JCI67227
HPA Axis / Cortisol → Cognition. “Whereas treatments used in previous studies generally affect more than one memory phase and therefore cannot detect possible differential effects of glucocorticoids on the distinct phases of acquisition, consolidation and retrieval, here we show that treatment of healthy humans with cortisone at acute-stress levels specifically impaired retrieval of declarative long-term memory for a word list.” — Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nature Neuroscience, 2000, vol 3, pp 313-314. doi:10.1038/73873
HPA Axis / Cortisol → Digestive Function. “Reports have consistently established that central administration of CRF acts in the brain to inhibit gastric emptying while stimulating colonic motor function through modulation of the vagal and sacral parasympathetic outflow in rodents.” — Corticotropin-Releasing Factor and the Brain-Gut Motor Response to Stress. Canadian Journal of Gastroenterology, 1999, vol 13, pp 18A-25A. doi:10.1155/1999/375916
HPA Axis / Cortisol → Prolactin. “Stress is also an important physiologic cause of hyperprolactinemia, and its clinical significance is still being explored.” — Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach. Obstetrics and Gynecology International, 2018, volume 2018, article ID 9253083. doi:10.1155/2018/9253083
Formulas that act on these pathways
Acts on 8 of these pathways: Stress Resilience, HPA Axis / Cortisol, Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance, Endocannabinoid Signaling.
Acts on 6 of these pathways: HPA Axis / Cortisol, Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance.
Acts on 6 of these pathways: HPA Axis / Cortisol, Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance.
Acts on 6 of these pathways: HPA Axis / Cortisol, Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance.
Acts on 5 of these pathways: Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance.
Acts on 5 of these pathways: Nrf2, NF-κB, AMPK, SIRT1, Immune Surveillance.
What this page does not claim
This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Stress Resilience. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.